- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06980220
- Original Trial
Impact of Perineal Massage With Lubricating Gel During Expulsion on Perineal Outcomes
May 12, 2025 updated by: Centre Hospitalier de Gonesse
The primary goal is to assess whether this practice reduces the incidence and severity of perineal tears.
Secondary objectives include evaluating the impact of the massage on perineal pain in the postpartum period and on the episiotomy rate.
Participants will include primiparous women with singleton pregnancies who delivered spontaneously via vaginal birth.
Exclusion criteria include instrumental deliveries, breech presentations, and preterm births.
Data will be collected through a questionnaire filled out by midwives immediately after birth, as well as additional data extracted from medical records.
All data will be anonymized using a birth number code.
The questionnaire collects information on whether a perineal massage was performed, the type of product used, the birth position, use of warm compresses, performance of the Ritgen maneuver, and perineal outcomes.
The medical record will provide demographic and clinical data, including the mother's age, BMI, labor duration, pushing time, newborn weight, and head circumference.
The study aims to provide evidence on whether perineal massage with gel at expulsion is an effective strategy to prevent severe perineal trauma and improve postpartum recovery.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
52
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gonesse, France
- France
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The study will select participants from primiparous women (first-time mothers) who have delivered through spontaneous vaginal births at the hospital.
The population will consist of women with singleton pregnancies who are undergoing vaginal delivery without any complications requiring instrumental intervention or preterm delivery.
The study will focus on a cohort of women who have received care from midwives, ensuring consistency in the delivery approach.
Participants will be selected based on the inclusion criteria outlined and will be monitored for perineal outcomes, including the occurrence of perineal tears and postpartum pain.
Description
Inclusion Criteria:
- Singleton pregnancy
- Spontaneous vaginal delivery
- Primiparous women (first-time mothers)
Exclusion Criteria:
- Instrumental births
- In-seat births
- Premature births
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of Perineal Tears Following Perineal Massage with Lubricating Gel at Expulsion
Time Frame: 15/10/2023 - 15/05/2024
|
15/10/2023 - 15/05/2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2023
Primary Completion (Actual)
May 15, 2024
Study Completion (Actual)
May 15, 2024
Study Registration Dates
First Submitted
May 12, 2025
First Submitted That Met QC Criteria
May 12, 2025
First Posted (Estimated)
May 20, 2025
Study Record Updates
Last Update Posted (Estimated)
May 20, 2025
Last Update Submitted That Met QC Criteria
May 12, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 0043_MATERNITE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Episiotomy
-
Universidad PanamericanaUniversidad de la Salud - UNISA; IMSS-Bienestar; Secretaría de Educación, Ciencia...Not yet recruitingEpisiotomy | Episiotomy Wound | Episiotomy Extended by Laceration | Episiotomy Infection
-
Alaa Nadhim HameedCompletedEpisiotomy Wound | Normal Vaginal Delivery | Episiotomy Infection | Surgical Site Infection PreventionIraq
-
Ain Shams UniversityLobna Ahmed Nabil; Dr. Ahmed Sherif; Dr. Mohamed Mahmoud El Sherbiny; Prof. Mohamed... and other collaboratorsCompletedEpisiotomy
-
Batman Training and Research HospitalBatman UniversityCompletedEpisiotomy | Episiotomy Extended by Laceration | Pelvic Floor AwarenessTurkey (Türkiye)
-
Muhammad Aamir LatifCompletedEpisiotomy WoundPakistan
-
Sharon Davidesko MDRecruitingEpisiotomy; Complications | Episiotomy Extended by Laceration | Episiotomy InfectionIsrael
-
Ayşegül KanıkRecruiting
-
Ain Shams UniversityUnknown
-
Aesculap AGB.Braun Surgical SACompleted
-
Ain Shams UniversityUnknown